Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series C
Manufacturing
Antheia seals 2nd series C funding close, hitting $175M
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.
Joseph Keenan
Jan 28, 2026 11:55am
Veradermics grows hair loss med hopes on $150M funding wave
Oct 16, 2025 7:30am
Varda nets $187M series C for drug manufacturing in space
Jul 14, 2025 7:38am
Narcan ingredient maker Antheia reels in $56M series C funding
Jun 4, 2025 9:51am
Cell therapy manufacturer Cellares draws $255M investment round
Aug 24, 2023 9:15am
VectorBuilder bags $57M to build out gene delivery capabilities
Oct 25, 2022 8:45am